17
Participants
Start Date
October 31, 2010
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
Aralast NP 45 mg dose
\- 45 mg/kg/week
Aralast NP 90 mg dose
\- 90 mg/kg/week
Aralast NP 180 mg dose
\- 180 mg/kg/week
Naomi Berrie Diabetes Center (Columbia University), New York
Children's Hospital of Philadelphia, Philadelphia
University of Maryland Medical Center, Baltimore
Atlanta Diabetes Associates, Atlanta
Children's Hospital of Atlanta (Emory University), Atlanta
Nationwide Children's Hospital, Columbus
University of Iowa Children's Hospital, Iowa City
Children's Mercy Hospital, Kansas City
Barbara Davis Center (University of Colorado), Aurora
RADY Children's Hospital (University of California, San Diego), San Diego
Pacific Northwest Research Institute-University of Washington, Seattle
Yale University, New Haven
Massachusetts General Hospital, Boston
Joslin Diabetes Center, Boston
University of Massachusetts Memorial Medical Center, Worcester
Collaborators (1)
Immune Tolerance Network (ITN)
NETWORK
Juvenile Diabetes Research Foundation
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH